Stephanie M Perez

8PUBLICATIONS
7CO-AUTHORS
Major global burdens of diseaseToxicology (incl. clinical toxicology)Psychology of ageingPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 04, 2026
Hippocampal 5-HT4/6 Receptor Antagonists Normalize Dopaminergic Dysfunction in a Rodent Model of Alzheimer's Disease.

|Jul 30, 2026
A cortical insula-orbitofrontal circuit drives stress-induced dopamine system dysfunction.

|Jul 29, 2023
α5-GABAA Receptor Modulation Reverses Behavioral and Neurophysiological Correlates of Psychosis in Rats with Ventral Hippocampal Alzheimer's Disease-like Pathology.

Nicole E Eassa, Stephanie M Perez, Angela M Boley

|Apr 28, 2023
Aberrant Dopamine System Function in the Ferrous Amyloid Buthionine (FAB) Rat Model of Alzheimer's Disease.

Stephanie M Perez, Angela M Boley, Alexandra M McCoy

|Nov 17, 2022
Increased Presynaptic Dopamine Synthesis Capacity Is Associated With Aberrant Dopamine Neuron Activity in the Methylazoxymethanol Acetate Rodent Model Used to Study Schizophrenia-Related Pathologies.

Stephanie M Perez, Hannah B Elam, Daniel J Lodge

|Feb 09, 2021
Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis.

Hannah B Elam, Stephanie M Perez, Jennifer J Donegan

Pageof 2

Frequent Collaborators

4 joint publications

Daniel J Lodge

4 joint publications

Hannah B Reiley

1 joint publications

Alexandra M McCoy

1 joint publications

Nicole E Eassa